Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Biotron.
RELATED STOCKHEAD STORIES
Health & Biotech
Pharmaxis dealt another blow as partner backs out of second drug development
News
10 at 10: These ASX stocks are leading the rally this morning
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Aussie biotechs join crusade for COVID-19 cure
Health & Biotech
The 6 ASX small cap biotechs that have more than doubled in 2020
Experts
Scopo’s health powerplays: The cash caboose keeps rolling on
News
Lunchtime ASX small cap wrap: Who’s got the bear by the tooth today?
Health & Biotech
Health: Biotron’s anti-HIV therapy could mean patients may not need treatment forever
Health & Biotech
Gone viral: COVID-19 is making Jatenergy, AuMake so very rich
Health & Biotech
Your guide to COVID-19 vaccines: it’ll all be over soon
Health & Biotech
Dr Boreham’s Crucible: The small cap biotechs trying to make a buck from coronavirus
News
February Winners Column: Wannabe virus fighters ride high in a rough month for stocks
Health & Biotech
Here’s how to pick a successful drug out of the 99pc of failures
Health & Biotech
Dr Boreham’s Crucible: Cochlear can weather the coronavirus-induced China slump
Health & Biotech
Check up: Who’s in your coronavirus portfolio?
News
